Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets.
about
NKT cells stimulated by long fatty acyl chain sulfatides significantly reduce the incidence of type 1 diabetes in nonobese diabetic mice [corrected]The role of NKT cells in tumor immunityThe Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8(+) T Cell GenerationDendritic cell subsets in type 1 diabetes: friend or foe?Natural killer T cells in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitisImmunogenetics of type 1 diabetes mellitusInnate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loop.A recombinant heavy chain antibody approach blocks ART2 mediated deletion of an iNKT cell population that upon activation inhibits autoimmune diabetesCD1d ligation on human monocytes directly signals rapid NF-kappaB activation and production of bioactive IL-12.Glycolipid antigen induces long-term natural killer T cell anergy in mice.CD1d and invariant NKT cells at the human maternal-fetal interface.NK cells are not required for spontaneous autoimmune diabetes in NOD mice.NKT cells: potential targets for autoimmune disease therapy?Invariant NKT Cell Lines Derived from the NOD·H2 Mouse Enhance Autoimmune Thyroiditis.The CD1 family and T cell recognition of lipid antigens.Lowering anti-dsDNA antibodies--what's new?Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay.Gene- and cell-based therapeutics for type I diabetes mellitus.Innate self recognition by an invariant, rearranged T-cell receptor and its immune consequences.Understanding the function of CD1-restricted T cells.NKT cells inhibit antigen-specific effector CD8 T cell induction to skin viral proteins.Dendritic cells, T cell tolerance and therapy of adverse immune reactions.Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivoCD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion.A locus on mouse chromosome 13 inversely regulates CD1d expression and the development of invariant natural killer T-cells.Beta-glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disordersGenetic control of murine invariant natural killer T-cell development dynamically differs dependent on the examined tissue type.CD1d-restricted T-cell subsets and dendritic cell function in autoimmunity.Natural killer T cells as targets for immunotherapy of autoimmune diseases.NKT cells and viral immunity.Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cells.Going both ways: immune regulation via CD1d-dependent NKT cells.alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles.The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice.Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cellsAlpha-lactosylceramide as a novel "sugar-capped" CD1d ligand for natural killer T cells: biased cytokine profile and therapeutic activities.Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupusStaphylococcus enterotoxin B-induced T cells can efficaciously protect against type 1 diabetes in non-obese diabetic miceImmunotherapy for the prevention and treatment of type 1 diabetes.The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.
P2860
Q21134826-49757313-9535-4167-85CC-658A2AEFAC7BQ24648939-B40B18C3-6AAB-495F-A850-40AE93F3CFC9Q26797344-3F36AE64-C890-4124-8B9B-B6A190297BB8Q26866500-A1581ADC-040A-488A-9B84-0AA4688F8A52Q28085038-BB85530B-E5CA-49CB-8EC9-C658E3B7EF40Q28087365-5ABE1FD6-AD70-466D-B1AC-E8665A599D05Q33618864-EF8F9E74-CE45-4064-96EF-FAEF4998FE0DQ33653646-800B1028-3A12-49B6-9B7E-BCE0C33EE9F1Q33920135-2304D96E-1821-42D1-8749-D31F423663AFQ33930869-8ECCFA4B-6877-4109-8232-0E5B66D946D1Q34160929-E81B056A-2A2B-4543-B59B-64929E985551Q34257031-5DA464B1-33B4-4C14-B3E6-909C5F9FE815Q34764715-5F26F76F-1E27-4BF6-BF9B-E3E286A4ACEBQ34985362-3E61331A-F945-4F19-A843-09806A768953Q35030902-C73D5133-287C-4771-940F-0B7CFD897206Q35045927-22283923-75C5-4CD1-8CCD-C6FBC980730FQ35102253-AD917A8B-501C-4C06-BB52-DEA1A33D120CQ35122170-8F7D553E-7197-4585-BB29-95101FBAA53BQ35131643-13DBA7AC-3DCE-469F-A207-EAABA59F3CB1Q35139857-D46A8E80-3361-460C-A7CA-9AAE8568ECF8Q35147733-490CC889-5337-4933-917B-E60C867559CBQ35161161-F21EEAD4-AF64-4632-B755-CA1C71B1995FQ35168204-C6B24E32-429F-4F77-9A76-9F5195E94A6DQ35171011-098512EE-EB84-4BBF-A7EE-1A206E502BC7Q35537082-50A59FDE-245C-488E-B12A-4216B953059DQ35761273-BC1A6C2E-013E-4360-9C5F-E9DEC7E77B17Q35795122-19DD548A-FEED-4C61-80E5-8BB20C5B60DBQ35798159-D66421AA-74EA-4DA3-8725-DE3671DAF6FAQ35798168-09E6A078-7D89-45A6-814E-4316F4DB56EDQ35798179-BF8EF5D2-0CF7-4683-90A6-D6CC15B86C01Q35901700-98C595A0-07DA-494C-9DCA-6485B9EFB635Q35951531-91BFB33F-410D-4238-93B2-36CE6B378A6CQ35998799-CEE70D8C-2834-4ED9-A81B-982349445CD5Q36079920-2E6350D1-8BC4-498D-97E2-83FC1C12531FQ36081961-8C5E1DBA-3208-4310-A0BD-FB7ACC512BD4Q36099369-1C8B03B1-0729-46CE-AB93-EC70A737EA38Q36259479-655A6B28-B57A-4D7F-88C3-96B7F208D007Q36305597-871314F0-6E53-4D3E-BE6E-A15D09B6364BQ36327355-B1E7A5F0-64BA-450C-80AF-8F9DF5BFF657Q36367836-A211BB50-129C-4446-9962-2C3BA034DC97
P2860
Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Activation of CD1d-restricted ...... lating dendritic cell subsets.
@ast
Activation of CD1d-restricted ...... lating dendritic cell subsets.
@en
type
label
Activation of CD1d-restricted ...... lating dendritic cell subsets.
@ast
Activation of CD1d-restricted ...... lating dendritic cell subsets.
@en
prefLabel
Activation of CD1d-restricted ...... lating dendritic cell subsets.
@ast
Activation of CD1d-restricted ...... lating dendritic cell subsets.
@en
P2093
P2860
P356
P1476
Activation of CD1d-restricted ...... lating dendritic cell subsets.
@en
P2093
K S Bahjat
M Clare-Salzer
R Gausling
S B Wilson
Y N Naumov
P2860
P304
13838-13843
P356
10.1073/PNAS.251531798
P407
P577
2001-11-13T00:00:00Z